Abraham Fong

Abraham Fong has a diverse work experience in the medical field. Abraham is currently working as the Vice President at Adcentrx Therapeutics since May 2023. Previously, they worked at ALX Oncology, where they held the position of Executive Medical Director from January 2022 to April 2023, and Senior Medical Director from March 2020 to January 2022. Before that, they worked at AbbVie as a Medical Director from November 2017 to March 2020. Abraham also has experience at Seattle Genetics, where they served as a Medical Director from September to November 2017, and as an Associate Medical Director from January 2015 to August 2017. Abraham started their career as a Research Associate at the Fred Hutchinson Cancer Research Center from July 2010 to January 2015. Abraham also had teaching roles at Seattle Children's Hospital and Seattle Children's as an Assistant Professor, Acting Assistant Professor, and Acting Instructor.

Abraham Fong has an extensive education history in the field of medicine. Abraham started their academic journey at UCLA from 1993 to 1997, where they earned their Bachelor of Science (B.S.) degree in Biology, General. Following that, they enrolled at the Pennsylvania State University College of Medicine from 1997 to 2004, where they pursued a MD, PhD degree in Medicine, Cellular & Molecular Biology. After completing their doctoral studies, Abraham Fong joined the Lucile Packard Children's Hospital, Stanford University Medical Center as a Resident in their Pediatrics Residency Program from 2004 to 2007. Finally, they continued to expand their expertise by joining the Seattle Children's Hospital where they served as a Fellow in their Pediatric Hematology-Oncology Fellowship Program from 2007 to 2010.